Skip to main content
Clinical Trials/CTRI/2018/10/016137
CTRI/2018/10/016137
Not yet recruiting
Phase 3

A comparative study of injection 0.25% bupivacaine and injection 0.25% ropivacaine for their duration of post-operative analgesia in USG guided transversus abdominis plane block for open abdominal surgeries

IGIMS0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K00-K95- Diseases of the digestive systemHealth Condition 2: N00-N99- Diseases of the genitourinary systemHealth Condition 3: C00-D49- NeoplasmsHealth Condition 4: O00-O9A- Pregnancy, childbirth and the puerperium
Sponsor
IGIMS
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
IGIMS

Eligibility Criteria

Inclusion Criteria

  • Patient of physical status 1\&2
  • Patient willing to participate
  • Patient undergoing open abdominal surgery

Exclusion Criteria

  • Patient refusal to participate
  • Patient with known sensitivity to local anesthetics
  • Patient with infection at injection site
  • patient with clotting abnormalities

Outcomes

Primary Outcomes

Not specified

Similar Trials